Membrane Dysfunction as a Central Mechanism in LRRK2-Associated Parkinson's Disease: Comparative Analysis of G2019S and I1371V Variants. [PDF]
Singh K +9 more
europepmc +1 more source
Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies. [PDF]
Dzamko N.
europepmc +1 more source
A Developmental Taxonomy of Autism and the Precision Timing of the Cheung Glutamatergic Regimen. [PDF]
Cheung N.
europepmc +1 more source
APOE, Aβ42, and tau differentially impact cognitive decline in Sporadic, GBA1 and LRRK2 Parkinson's disease. [PDF]
Botta R +4 more
europepmc +1 more source
Multi-cohort, cross-species urinary proteomics reveals signatures of LRRK2 dysfunction in Parkinson's disease. [PDF]
Vu DT +15 more
europepmc +1 more source
LRRK2 controls COX assembly through regulation of redox status of mitochondrial copper chaperones. [PDF]
Kim TY, Jang EH, Bae YH, Hur EM, Lee BD.
europepmc +1 more source
LRRK2<sup>R1627P</sup> mutation amplifies environmental risk factors induced chronic inflammation and α-synuclein aggregation in the gut of rats. [PDF]
Pang S +7 more
europepmc +1 more source
Zebrafish Models of Parkinson's Disease: From Pathogenesis to Drug Discovery. [PDF]
Park HC, Seo Y, Han YJ, Cho SH, Kim MJ.
europepmc +1 more source
Dysregulation of astrocytic DNAJC6 contributes to sporadic Parkinson's disease pathogenesis. [PDF]
Darsono WHW +9 more
europepmc +1 more source
Parkinson's Disease Patient-Specific Striatum Organoids Show Hallmarks of Increased Inflammation. [PDF]
Barmpa K +11 more
europepmc +1 more source

